December 4, 2017 – BOSTON MA AND PARAMUS N.J., – Blue Oak Pharmaceuticals, Inc. (Blue Oak) and PGI Drug Discovery LLC (PsychoGenics), today announced that they have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions
